SG10201500036WA - Highly-purified soluble thrombomodulin and method for producing same - Google Patents

Highly-purified soluble thrombomodulin and method for producing same

Info

Publication number
SG10201500036WA
SG10201500036WA SG10201500036WA SG10201500036WA SG10201500036WA SG 10201500036W A SG10201500036W A SG 10201500036WA SG 10201500036W A SG10201500036W A SG 10201500036WA SG 10201500036W A SG10201500036W A SG 10201500036WA SG 10201500036W A SG10201500036W A SG 10201500036WA
Authority
SG
Singapore
Prior art keywords
highly
producing same
soluble thrombomodulin
purified soluble
purified
Prior art date
Application number
SG10201500036WA
Other languages
English (en)
Inventor
Yuji Ueno
Hiroki Shigematsu
Original Assignee
Asahi Kasei Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Pharma Corp filed Critical Asahi Kasei Pharma Corp
Publication of SG10201500036WA publication Critical patent/SG10201500036WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/7455—Thrombomodulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
SG10201500036WA 2010-04-30 2011-04-28 Highly-purified soluble thrombomodulin and method for producing same SG10201500036WA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010105421 2010-04-30

Publications (1)

Publication Number Publication Date
SG10201500036WA true SG10201500036WA (en) 2015-02-27

Family

ID=44861609

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201500036WA SG10201500036WA (en) 2010-04-30 2011-04-28 Highly-purified soluble thrombomodulin and method for producing same
SG2012075115A SG184530A1 (en) 2010-04-30 2011-04-28 Highly-purified soluble thrombomodulin and method for producing same

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2012075115A SG184530A1 (en) 2010-04-30 2011-04-28 Highly-purified soluble thrombomodulin and method for producing same

Country Status (10)

Country Link
US (2) US9127089B2 (de)
EP (2) EP2565269B1 (de)
JP (3) JP5722314B2 (de)
KR (1) KR101486835B1 (de)
AU (1) AU2011246021B2 (de)
CA (1) CA2796452C (de)
NZ (1) NZ602852A (de)
SG (2) SG10201500036WA (de)
TW (2) TW201522633A (de)
WO (1) WO2011136313A1 (de)

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2738428B2 (ja) 1987-01-08 1998-04-08 旭化成工業株式会社 トロンビンによるプロテインｃの活性化を促進する作用を有するペプチド
DE3856335T2 (de) 1987-01-08 2000-01-27 Asahi Kasei Kogyo K.K., Osaka Peptid zur beschleunigung der wirkung des proteins-c mit thrombin
DK299087D0 (da) 1987-06-12 1987-06-12 Novo Industri As Proteins and derivatives thereof
EP0356395A3 (de) 1988-08-26 1991-09-04 Ciba-Geigy Ag Flankierende Peptide und Verfahren zu ihrer Herstellung
JPH0720997B2 (ja) 1988-08-29 1995-03-08 興和株式会社 新規なトロンビン結合性物質及びその製法
JPH0798840B2 (ja) 1988-12-27 1995-10-25 持田製薬株式会社 尿由来の抗血液疑固物質、その製法およびそれを含有する医薬組成物
US5202421A (en) 1988-12-27 1993-04-13 Mochida Pharmaceutical Co., Ltd. Anticoagulant substance obtained from urine and process for the preparation thereof
JPH02255699A (ja) 1989-03-28 1990-10-16 Asahi Chem Ind Co Ltd 新規血液抗凝固物質及びその製法
US5466668A (en) 1989-04-28 1995-11-14 Schering Aktiengesellschaft Superior thrombomodulin analogs for pharmaceutical use
US6063763A (en) 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
CA2022713A1 (en) 1989-08-11 1991-02-12 Nils U. Bang Human thrombomodulin derivatives
WO1991005803A1 (en) 1989-10-18 1991-05-02 Daiichi Pharmaceutical Co., Ltd. Recombinant human thrombomodulin
JPH03259084A (ja) 1990-03-06 1991-11-19 Kowa Co トロンビン結合性物質の製造法
WO1992000325A1 (en) 1990-06-27 1992-01-09 Mochida Pharmaceutical Co., Ltd. Anticoagulant polypeptides
JPH05213998A (ja) 1990-08-03 1993-08-24 Asahi Chem Ind Co Ltd 新規なポリペプチド及びこれを有効成分とする 医薬組成物
KR930008093B1 (ko) 1990-08-03 1993-08-25 아사히가세이고오교 가부시끼가이샤 신규 폴리펩티드 및 이를 유효성분으로 하는 의약조성물
DE69132889T2 (de) 1990-08-15 2002-08-29 Paion Gmbh Überlegende thrombomodulinanaloga zur pharmazeutischen verwendung
JP3220174B2 (ja) 1990-12-12 2001-10-22 第一製薬株式会社 組換ヒトトロンボモジュリン誘導体
CA2129370A1 (en) 1992-02-05 1993-08-19 David Richard Light Protease-resistant thrombomodulin analogs
JPH05310787A (ja) 1992-05-01 1993-11-22 Asahi Chem Ind Co Ltd 新規なポリペプチド
JPH0646219A (ja) 1992-07-23 1994-02-18 Ricoh Co Ltd 画像情報読取装置
US5378816A (en) 1992-12-16 1995-01-03 Berlex Laboratories, Inc. Methods for high purity chromatographic separation of proteins having EGF-like binding domains
JP3439503B2 (ja) 1993-06-28 2003-08-25 旭化成株式会社 蛋白質分離精製方法
AU692497B2 (en) * 1993-12-17 1998-06-11 Asahi Kasei Pharma Corporation Soluble thrombomodulin-containing pharmaceutical composition
JP2824392B2 (ja) 1994-05-31 1998-11-11 旭化成工業株式会社 トロンビンによるプロテインｃの活性化を促進する作用を有するペプチドを含有する培養上澄液
JPH08280384A (ja) 1995-04-18 1996-10-29 Toyobo Co Ltd 有核細胞を含む試料から核酸または蛋白質を回収する方法
JP3745805B2 (ja) 1995-10-24 2006-02-15 日本ケミカルリサーチ株式会社 トロンボモジュリンの精製方法
JP4157644B2 (ja) 1998-03-30 2008-10-01 旭化成ファーマ株式会社 高純度可溶性トロンボモジュリンの製造方法
FR2810667B1 (fr) 2000-06-23 2004-09-03 Warner Lambert Co Procede d'isolement et de purification d'une proteine, et proteine obtenue
GB0100513D0 (en) 2001-01-09 2001-02-21 Smithkline Beecham Plc Process
JP4340540B2 (ja) 2002-01-18 2009-10-07 旭化成ファーマ株式会社 可溶性トロンボモジュリン高濃度含有製剤
JP2007016016A (ja) 2005-06-09 2007-01-25 Toray Ind Inc 分画方法および分画装置
JP5707025B2 (ja) 2005-09-15 2015-04-22 ワイス・エルエルシー 塩を用いた蛋白のフロキュレーション
WO2008117735A1 (ja) 2007-03-23 2008-10-02 Asahi Kasei Pharma Corporation 高純度可溶性トロンボモジュリンの製造方法
FR2920429B1 (fr) 2007-08-30 2012-10-05 Lfb Biotechnologies Procede de purification du facteur viii et du facteur von willebrand
JP2010051927A (ja) 2008-08-29 2010-03-11 Asahi Kasei Corp 限外濾過膜を用いた生体成分の分離方法およびモジュール、装置

Also Published As

Publication number Publication date
EP2565269A1 (de) 2013-03-06
JP5722314B2 (ja) 2015-05-20
CA2796452C (en) 2017-12-05
JP2015071646A (ja) 2015-04-16
EP2565269A4 (de) 2013-11-27
EP3150628A1 (de) 2017-04-05
US20130143790A1 (en) 2013-06-06
JP2016014067A (ja) 2016-01-28
WO2011136313A1 (ja) 2011-11-03
AU2011246021B2 (en) 2014-03-13
SG184530A1 (en) 2012-11-29
CA2796452A1 (en) 2011-11-03
TW201522633A (zh) 2015-06-16
JPWO2011136313A1 (ja) 2013-07-22
KR20130031262A (ko) 2013-03-28
CN102858978A (zh) 2013-01-02
KR101486835B1 (ko) 2015-01-30
EP2565269B1 (de) 2016-11-16
TWI546382B (zh) 2016-08-21
JP5873578B2 (ja) 2016-03-01
TW201204832A (en) 2012-02-01
NZ602852A (en) 2014-03-28
US20150322133A1 (en) 2015-11-12
US9127089B2 (en) 2015-09-08

Similar Documents

Publication Publication Date Title
EP2634144A4 (de) Aerogel und verfahren zu seiner herstellung
EP2505684A4 (de) Getriebe und herstellungsverfahren dafür
EP2538467A4 (de) Batterie und verfahren zu ihrer herstellung
EP2546291A4 (de) Schaumstoffzusammensetzung, herstellungsverfahren dafür und schaumstoff
EP2554366A4 (de) Beschichtung und herstellungsverfahren dafür
EP2589815A4 (de) Antrieb und verfahren zu seiner herstellung
EP2441738A4 (de) Dehnbare zusatzmischung und herstellungsverfahren dafür
PL2576477T3 (pl) Granulowany pumeks i sposób jego wytwarzania
HK1164795A1 (en) Laminate and method for producing same
EP2537825A4 (de) Verfahren zur herstellung von 1-amino-1-alkoxycarbonyl-2-vinylcyclopropan
EP2657223A4 (de) Metall-salen-komplex und herstellungsverfahren dafür
HK1188182A1 (en) Method for producing ornament
EP2571049A4 (de) Elektronische komponente und herstellungsverfahren dafür
SG10201604976RA (en) Hydroxy-aminopolymers and method for producing same
PL2569427T3 (pl) Sposób wytwarzania alkoholu paczulowego i 7-epi-alfa-selinenu
EP2537963A4 (de) Metalllaminatstruktur und herstellungsverfahren dafür
IL222184A (en) Amino-pyridine-n- oxides are converted and methods of preparation
IL232681A0 (en) A method for the production of pyridazinone compounds and its intermediates
EP2653481A4 (de) Verfahren zur herstellung von pseudopolyrotaxan
EP2653482A4 (de) Verfahren zur herstellung von pseudopolyrotaxan
LT3067219T (lt) Panelių gamybos būdas
IL226569A (en) Final pressure / compression finish of a sealant die and a method of manufacturing it
HK1158029A1 (en) Cystine-containing complex and method for producing the same
HUP1100236A2 (en) Method for producing form pieces
EP2554649A4 (de) Eingekapselter schaumstoff und verfahren zur herstellung davon